BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30359631)

  • 1. Local delivery of macromolecules to treat diseases associated with the colon.
    Bak A; Ashford M; Brayden DJ
    Adv Drug Deliv Rev; 2018; 136-137():2-27. PubMed ID: 30359631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches and opportunities in colon-specific drug delivery.
    Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):101-49. PubMed ID: 9501968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic treatments and targets: issues and opportunities.
    McConnell EL; Liu F; Basit AW
    J Drug Target; 2009 Jun; 17(5):335-63. PubMed ID: 19555265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic opportunities in colon-specific drug-delivery systems.
    Patel M; Shah T; Amin A
    Crit Rev Ther Drug Carrier Syst; 2007; 24(2):147-202. PubMed ID: 17725524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon-targeted oral drug delivery systems: design trends and approaches.
    Amidon S; Brown JE; Dave VS
    AAPS PharmSciTech; 2015 Aug; 16(4):731-41. PubMed ID: 26070545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral colon delivery: rationale and time-based drug design strategy.
    Gazzaniga A; Maroni A; Foppoli A; Palugan L
    Discov Med; 2006 Dec; 6(36):223-8. PubMed ID: 17250787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel strategies for the buccal delivery of macromolecules.
    Morales JO; McConville JT
    Drug Dev Ind Pharm; 2014 May; 40(5):579-90. PubMed ID: 24611816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Site-specific drug delivery systems. I. Colon targeted delivery].
    Szente V; Zelkó R
    Acta Pharm Hung; 2007; 77(3):185-9. PubMed ID: 18019784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in colonic drug delivery.
    Basit AW
    Drugs; 2005; 65(14):1991-2007. PubMed ID: 16162022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials.
    Brayden DJ
    BioDrugs; 2022 Nov; 36(6):687-700. PubMed ID: 36282433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon drug delivery.
    Van den Mooter G
    Expert Opin Drug Deliv; 2006 Jan; 3(1):111-25. PubMed ID: 16370944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
    Asghar LF; Chandran S
    J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-controlled oral delivery systems for colon targeting.
    Gazzaniga A; Maroni A; Sangalli ME; Zema L
    Expert Opin Drug Deliv; 2006 Sep; 3(5):583-97. PubMed ID: 16948555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azo compounds in colon-specific drug delivery.
    Roldo M; Barbu E; Brown JF; Laight DW; Smart JD; Tsibouklis J
    Expert Opin Drug Deliv; 2007 Sep; 4(5):547-60. PubMed ID: 17880276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs.
    Reddy SM; Sinha VR; Reddy DS
    Drugs Today (Barc); 1999 Jul; 35(7):537-80. PubMed ID: 12973398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting microspheres as a therapeutic proficient doer for colon delivery: a review.
    Vats A; Pathak K
    Expert Opin Drug Deliv; 2013 Apr; 10(4):545-57. PubMed ID: 23316745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in colon-targeted nano-drug delivery systems: challenges and solutions.
    Naeem M; Awan UA; Subhan F; Cao J; Hlaing SP; Lee J; Im E; Jung Y; Yoo JW
    Arch Pharm Res; 2020 Jan; 43(1):153-169. PubMed ID: 31989477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural products to improve quality of life targeting for colon drug delivery.
    Kim H
    Curr Drug Deliv; 2012 Mar; 9(2):132-47. PubMed ID: 22283651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The colon as a possible target for orally administered peptide and protein drugs.
    Haupt S; Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 2002; 19(6):499-551. PubMed ID: 12822734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.